1. Home
  2. ENVX vs NEO Comparison

ENVX vs NEO Comparison

Compare ENVX & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$4.88

Market Cap

1.3B

Sector

Miscellaneous

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.92

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVX
NEO
Founded
2006
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Precision Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
ENVX
NEO
Price
$4.88
$8.92
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$14.56
$11.14
AVG Volume (30 Days)
5.5M
2.0M
Earning Date
05-21-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
40.94
N/A
EPS
N/A
N/A
Revenue
$31,821,000.00
N/A
Revenue This Year
$40.85
$10.63
Revenue Next Year
$236.84
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
37.91
N/A
52 Week Low
$4.84
$4.72
52 Week High
$16.49
$13.74

Technical Indicators

Market Signals
Indicator
ENVX
NEO
Relative Strength Index (RSI) 30.07 26.03
Support Level N/A $7.20
Resistance Level $8.73 $8.89
Average True Range (ATR) 0.37 0.68
MACD -0.05 -0.09
Stochastic Oscillator 0.94 4.21

Price Performance

Historical Comparison
ENVX
NEO

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: